FDA.reportPublic FDA data

aliskiren 150 MG / hydrochlorothiazide 25 MG Oral Tablet

RxCUI
1011713
RxNorm name
aliskiren 150 MG / hydrochlorothiazide 25 MG Oral Tablet
Display name
Aliskiren/hydroCHLOROthiazide (Oral Pill)
Full name
aliskiren 150 MG / hydrochlorothiazide 25 MG Oral Tablet
Term type
SCD
Status
Active
Strength
150-25 mg
Dose form
Tab
Route
Oral Pill
Updated
2026-10-26 03:52:36

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
102010
Active start
102010
Multiple ingredient
YES
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
aliskiren hemifumarate150 MG / 1 EACHaliskirenaliskiren
hydrochlorothiazide25 MG / 1 EACHhydrochlorothiazidehydrochlorothiazide

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Tablet317541

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
aliskiren325646
hydrochlorothiazide5487

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRaliskiren 150 MG / hydroCHLOROthiazide 25 MG Oral Tablet1NAMES
RxNorm Namealiskiren 150 MG / hydrochlorothiazide 25 MG Oral Tablet1NAMES
RxNorm Synonymaliskiren 150 MG / HCTZ 25 MG Oral Tablet1NAMES
TTYSCD1ATTRIBUTES
RxCUI10117131CODES
MMSL_CODECD228311CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 4 matching rows.

NDC11, Source, Active table
NDC11SourceActive
00078052215rxnav_historical_indirect
00078052234rxnav_historical_indirect
00078052235rxnav_historical_indirect
66828002501rxnav_historical_indirect

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
8df0ca6a-58cf-41fc-b890-5c7fa5a3792caliskiren 150 MG / hydroCHLOROthiazide 25 MG Oral Tablet [PSN] · aliskiren 150 MG / hydrochlorothiazide 25 MG Oral Tablet [SCD] · aliskiren 150 MG / HCTZ 25 MG Oral Tablet [SY]311These highlights do not include all the information needed to use TEKTURNA HCT safely and effectively. See full prescribing information for TEKTURNA HCT. TEKTURNA ® HCT (aliskiren and hydrochlorothiazide) tablets, for oral use Initial U.S. Approval: 200820221116

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
964f81ad-15fa-41d2-ac03-c3f09347e495National Council for Prescription Drug Programs20120724

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCC09XARenin-inhibitorsATC1-4aliskiren
ATCC09XARenin-inhibitorsATC1-4aliskiren / hydrochlorothiazide
ATCC03AAThiazides, plainATC1-4hydrochlorothiazide
FDASPLD049971ThiazidesCHEMhas_chemical_structurehydrochlorothiazide
FDASPLN0000175900Renin InhibitorEPChas_epcaliskiren
FDASPLN0000175419Thiazide DiureticEPChas_epchydrochlorothiazide
FDASPLN0000175899Renin InhibitorsMOAhas_moaaliskiren
FDASPLN0000175359Increased DiuresisPEhas_pehydrochlorothiazide
MEDRTD000577AmidesCHEMhas_ingredientaliskiren
MEDRTD005650FumaratesCHEMhas_ingredientaliskiren
MEDRTD006852HydrochlorothiazideCHEMhas_ingredienthydrochlorothiazide
MEDRTD013449SulfonamidesCHEMci_chemclasshydrochlorothiazide
MEDRTD013449SulfonamidesCHEMci_chemclassaliskiren
MEDRTD001002AnuriaDISEASEci_withaliskiren
MEDRTD001002AnuriaDISEASEci_withhydrochlorothiazide
MEDRTD002675Child, PreschoolDISEASEci_withaliskiren
MEDRTD003920Diabetes MellitusDISEASEci_withaliskiren
MEDRTD004342Drug HypersensitivityDISEASEci_withhydrochlorothiazide
MEDRTD004487EdemaDISEASEmay_treathydrochlorothiazide
MEDRTD006333Heart FailureDISEASEmay_treathydrochlorothiazide
MEDRTD006967HypersensitivityDISEASEci_withaliskiren
MEDRTD006973HypertensionDISEASEmay_treataliskiren
MEDRTD006973HypertensionDISEASEmay_treathydrochlorothiazide
MEDRTD009404Nephrotic SyndromeDISEASEmay_treathydrochlorothiazide
MEDRTD011247PregnancyDISEASEci_withhydrochlorothiazide
MEDRTD051437Renal InsufficiencyDISEASEci_withhydrochlorothiazide
MEDRTN0000000181Angiotensin-converting Enzyme InhibitorsMOAci_moaaliskiren
MEDRTN0000000181Angiotensin-converting Enzyme InhibitorsMOAhas_moaaliskiren
MEDRTN0000175899Renin InhibitorsMOAci_moaaliskiren
MEDRTN0000175899Renin InhibitorsMOAhas_moaaliskiren
MEDRTN0000181005Sodium Chloride Symporter InhibitorsMOAhas_moahydrochlorothiazide
MEDRTN0000178477Decreased Blood PressurePEhas_pehydrochlorothiazide
MEDRTN0000178477Decreased Blood PressurePEhas_pealiskiren
MEDRTN0000008579Decreased Distal Tubule Ca++ ExcretionPEhas_pehydrochlorothiazide
MEDRTN0000008669Decreased Intravascular VolumePEhas_pehydrochlorothiazide
MEDRTN0000009274Increased Distal Tubule Cl- ExcretionPEhas_pehydrochlorothiazide
MEDRTN0000009275Increased Distal Tubule H+ ExcretionPEhas_pehydrochlorothiazide
MEDRTN0000009277Increased Distal Tubule K+ ExcretionPEhas_pehydrochlorothiazide
MEDRTN0000009279Increased Distal Tubule Na+ ExcretionPEhas_pehydrochlorothiazide
MEDRTN0000175359Increased DiuresisPEhas_pehydrochlorothiazide
MEDRTN0000009909VasodilationPEhas_pehydrochlorothiazide
MEDRTN0000000042Renal ExcretionPKhas_pkhydrochlorothiazide

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH150 MG / 25 MG
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
CODESSNOMEDCT1149400009
CODESVUID4027749
NAMESPrescribable Synonymaliskiren 150 MG / hydroCHLOROthiazide 25 MG Oral Tablet
NAMESTallman Synonymaliskiren 150 MG / hydroCHLOROthiazide 25 MG Oral Tablet
SOURCESSourceNational Drug Data File Plus Source Vocabulary
SOURCESSourceUS Edition of SNOMED_CT